Is Carboplatin Injection (Kyxata) in shortage?
Yes. Carboplatin Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why it’s in shortage
- Delay in shipping of the drug
- Demand increase for the drug
- Discontinuation of the manufacture of the drug
- Other
- Requirements related to complying with good manufacturing practices
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60)
Next release November 2026. Check wholesalers for inventory.
Maker contact: 888-386-1300
- Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12)
Estimated recovery: TBD/ NDC non-Exempt
Maker contact: 866-941-7875, option 2
- Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31)
Estimated recovery: TBD/ NDC non-Exempt
Maker contact: 866-941-7875, option 2
- Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33)
Estimated recovery: TBD/ NDC non-Exempt
Maker contact: 866-941-7875, option 2
- Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34)
Estimated recovery: TBD/ NDC non-Exempt
Maker contact: 866-941-7875, option 2
- Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01)
On backorder. Recovery: late October 2026. Check wholesalers for inventory
Maker contact: 888-238-7880
- Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01)
Check wholesalers for inventory
Maker contact: 888-238-7880
- Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01)
Estimated recovery: December 2028
Maker contact: 800-545-8800
- Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01)
Estimated recovery: January 2027
Maker contact: 800-545-8800
- Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01)
Estimated recovery: September 2027
Maker contact: 800-545-8800
- Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01)
Estimated recovery: February 2027
Maker contact: 800-545-8800
- Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug More from the maker
Maker contact: Apotex Inc.: 800-706-5575
- Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug More from the maker
Maker contact: Apotex Inc.: 800-706-5575
- Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug More from the maker
Maker contact: Apotex Inc.: 800-706-5575
- Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)
Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug More from the maker
Maker contact: Apotex Inc.: 800-706-5575
- Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05)
Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)
Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18)
Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027
Maker contact: 844-646-4398
- Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22)
Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50)
Limited Supply Available. Next Delivery and Estimated Recovery: December 2026
Maker contact: 844-646-4398
- Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56)
Limited Supply Available. Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18)
Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05)
Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
Maker contact: 844-646-4398
- Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01)
Discontinued; Distributed by BPI Labs, LLC
Maker contact: Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
- Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01)
Distributed by BPI Labs, LLC
Maker contact: Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
- Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01)
Recovery estimated in late Q4 2026; Distributed by BPI Labs, LLC
Maker contact: Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
- Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01)
Recovery estimated in late Q4 2026; Distributed by BPI Labs, LLC
Maker contact: Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
- Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08)
Maker contact: 877-595-7337; customerservice@avyxa.com
- Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)
Maker contact: 877-595-7337; customerservice@avyxa.com
- Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45)
Discontinuation of the manufacture of the drug
Maker contact: 866-321-5031
- Carboplatin, Injection, 600 mg/60 mL (NDC 50742-448-60)
Discontinuation of the manufacture of the drug
Maker contact: 866-321-5031
FDA recalls of Carboplatin
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Carboplatin Injection:
- Hospira Inc. recalls Carboplatin Injection, 600 mg/60 mL (10 mg/mL), 60 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use,
- Hospira Inc. recalls Carboplatin Injection, 450 mg/45 mL (10 mg/mL), 45 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use,
- Hospira Inc. recalls Carboplatin Injection, 10 mg/mL, a) 5 mL multi-dose vials (NDC 61703-339-18) (NDC 61703-360-18, NOVAPLUS), b) 45 mL
- Hospira Inc. recalls Carboplatin Injection, 10 mg/mL, 45 mL Multi-Dose Vial, Rx only, antineoplastic/cytotoxic agent; Manufactured for
Carboplatin Injection shortage questions
Is Carboplatin Injection (Kyxata) in shortage?
Yes. Carboplatin Injection is on FDA’s drug shortage list (unavailable), last updated Oct 6, 2026.
Why is there a Carboplatin Injection shortage?
FDA records the reason as: Delay in shipping of the drug; Demand increase for the drug; Discontinuation of the manufacture of the drug; Other; Requirements related to complying with good manufacturing practices.
What should I do if I can’t get Carboplatin Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.